Sign in
Taking people in United StatesPhase 3

Nitric oxide during heart surgery to protect the kidneys of newborns with heart defects

Tests nitric oxide for preventing kidney injury in newborns having heart surgery.

Key facts

Who runs it
Children's Hospital Medical Center, Cincinnati
Where
Cincinnati, United StatesSee the site
Trial code
Registry title
NO During CPB in Neonates to Reduce Risk of AKI
Status
Recruiting
Phase
Phase 3
People taking part
40 people, planned
Started
10 Jan 2023
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Nitric Oxide
  • Oxygen
Record updated
5 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for newborn babies up to 31 days old who are having heart surgery with a heart-lung machine (cardiopulmonary bypass) for a heart defect present from birth.

Age
1 Day to 31 Days (≤31 days)
Sex
All
Disease stage
Congenital heart disease that needs heart surgery with cardiopulmonary bypass. Emergency surgery is not included.
Earlier treatment
Babies cannot join if they recently had steroids (except steroids given for the bypass) or had inhaled NO (iNO) right before surgery. Babies taking other investigational drugs cannot join.

Main reasons for not taking part

  • Emergency surgery, or a cardiac arrest within 1 week before surgery
  • Kidney injury before surgery, or kidney structure problems seen on ultrasound
  • Signs of high blood pressure in the lungs that lasts, before surgery
  • Weight less than 2 kg (4 lb), or born before 36 weeks of pregnancy
  • Major birth defects outside the heart, or parents who do not speak English

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • All neonates (≤31 days) undergoing cardiac surgery with CPB for CHD will be deemed eligible for enrollment

Who cannot take part

  • Emergency surgery,
  • Episode of cardiac arrest within 1 week before surgery,
  • Recent treatment with steroids and/or a condition that may require treatment with steroids (excluding steroid administration specifically for CPB),
  • Use of inhaled NO (iNO) immediately prior to surgery,
  • Use of other investigational drugs,
  • Failure to obtain informed consent from parent/guardian
  • Gestational age <36 weeks,
  • Clinical signs of preoperative persistent elevated pulmonary vascular resistance,
  • Structural renal abnormalities by ultrasound,
  • Preoperative AKI,
  • Weight less than <2 kg,
  • Major extracardiac congenital anomalies,
  • Non-English speakers

Where in United States

  • Cincinnati Children's Hospital Medical CenterCincinnati, United StatesContact: David S. Cooper, MDTaking people

About the trial

What the trial wants to find out

Acute kidney injury (AKI) following cardiac surgery for congenital heart defects (CHD) in children affects up to 60% of high risk-patients and is a major cause of both short- and long-term morbidity and mortality. Despite effort, to date, no successful therapeutic agent has gained widespread success in preventing this postoperative decline in renal function. Nitric oxide is an intricate regulator of acute inflammation and coagulation and is a potent vasodilator. The investigators hypothesize that nitric oxide, administered during cardiopulmonary bypass (CPB), may reduce the incidence of AKI.

The 2 groups in the trial

  • Nitric OxideTreatment being tested

    Intraoperative NO entrained at 20 ppm into the oxygenator of the CPB circuit with standard care

  • OxygenPlacebo, for comparison

    Standard CPB without NO administered at any point intraoperatively

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy of Nitric Oxide Administration During Cardiopulmonary Bypass in Neonates at Reducing the Risk of Acute Kidney Injury
Plain-language title
Nitric oxide during heart surgery to protect the kidneys of newborns with heart defectsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
5 August 2026